Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Biohaven Pharmaceutical Holding Company Ltd.
  6. News
  7. Summary
    BHVN   VGG111961055

BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

(BHVN)
  Report
Real-time Estimate Cboe BZX  -  11:13 2022-08-12 am EDT
147.56 USD   -0.03%
08/08Pfizer Strikes $5.4 Billion Buyout Deal For Global Blood Therapeutics, Eyeing Sickle Cell Disease Portfolio
MT
08/08Biohaven reports second quarter 2022 financial results and reports recent business developments
AQ
08/08Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 bln deal
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sector Update: Health Care Stocks Still Edging Higher This Afternoon

05/10/2022 | 01:52pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. -0.01% 147.59 Delayed Quote.7.11%
EVAXION BIOTECH A/S 2.14% 2.86 Delayed Quote.-36.65%
INTRA-CELLULAR THERAPIES, INC. -3.68% 54.945 Delayed Quote.8.94%
MERCK & CO., INC. 0.73% 89.55 Delayed Quote.16.04%
NASDAQ COMPOSITE 1.05% 12915.33 Real-time Quote.-17.83%
PFIZER, INC. 2.12% 49.3275 Delayed Quote.-18.22%
All news about BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
08/08Pfizer Strikes $5.4 Billion Buyout Deal For Global Blood Therapeutics, Eyeing Sickle Ce..
MT
08/08Biohaven reports second quarter 2022 financial results and reports recent business deve..
AQ
08/08Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 bln deal
RE
08/08Wedbush Downgrades Biohaven Pharmaceutical to Neutral From Outperform, Noting Pfizer De..
MT
08/05BIOHAVEN PHARMACEUTICAL : REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND REPORTS RECENT..
PU
08/05BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. Management's Discussion and Analysis of Financ..
AQ
08/05Biohaven Pharmaceutical Holding Company Reports Bigger Q2 Loss Despite Higher Revenue
MT
08/05Earnings Flash (BHVN) BIOHAVEN PHARMACEUTICAL HOLDING COMPANY Posts Q2 Revenue $215.1M
MT
08/05Earnings Flash (BHVN) BIOHAVEN PHARMACEUTICAL HOLDING COMPANY Posts Q2 Loss $-3.82
MT
08/05Biohaven Pharmaceutical Holding Company Ltd. Reports Earnings Results for the Second Qu..
CI
More news
Analyst Recommendations on BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
More recommendations
Financials (USD)
Sales 2022 1 078 M - -
Net income 2022 -960 M - -
Net Debt 2022 212 M - -
P/E ratio 2022 -10,4x
Yield 2022 -
Capitalization 10 553 M 10 553 M -
EV / Sales 2022 9,99x
EV / Sales 2023 8,40x
Nbr of Employees 928
Free-Float 87,0%
Chart BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Duration : Period :
Biohaven Pharmaceutical Holding Company Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 147,61 $
Average target price 153,56 $
Spread / Average Target 4,03%
EPS Revisions
Managers and Directors
Vladimir Coric Chairman & Chief Executive Officer
Matthew Buten Chief Financial Officer
Charles Conway Chief Scientific Officer
Elyse Stock Chief Medical Officer
Melissa Beiner Director-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.7.11%10 553
MODERNA, INC.-32.35%67 212
LONZA GROUP AG-23.32%46 073
IQVIA HOLDINGS INC.-14.23%45 135
SEAGEN INC.12.57%32 099
ALNYLAM PHARMACEUTICALS, INC.35.27%27 533